StockDuty ← Dashboard Oct 14, 2026 04:36 AM ET
SignalCorporate

FTC wants Martin Shkreli held in contempt for trading pharma stocks

FTC wants Martin Shkreli held in contempt for trading pharma stocks

What happened: The FTC asked a federal judge to hold Martin Shkreli in contempt for allegedly violating a 2022 court order by trading pharma stocks and posting opinions about pharma companies. Key numbers: At least 60 pharma stocks traded; lifetime ban issued February 2022; released from prison May 2022; trading phases since July 2022; June 2026 challenge with $10M; Daraprim price raised to $750 per pill from $13.50; convicted 2017; seven years in prison Why it matters: The FTC is seeking divestment of his pharma stocks, a fine equal to his profits, and consequences for future violations. Market: +2.1% by next close ($323.07 on Oct 14), +12.7% YTD Coverage: 10 outlets in 24h
The FTC asked a federal judge to hold Martin Shkreli in contempt for allegedly violating a 2022 court order by trading pharma stocks and posting opinions about pharma companies.
The FTC is seeking divestment of his pharma stocks, a fine equal to his profits, and consequences for future violations. Market: +2.1% by next close ($323.07 on Oct 14), +12.7% YTD
Sources